Fleury S A : Sustainability Report - Short Version 2022

We are passionate about people and what we do.

Sustainability Report

2022

Short version

Future Strategy

The year 2022 represented an important step in the execution of our strategic planning. The results demonstrate the strength of our brands and the assertiveness of the path we have chosen to follow in recent years, focusing on innovation, customer satisfaction and the relationship with the medical community.

We aim to become one of the main players in the healthcare sector, acting throughout the value chain and leading the way in coordinating the patients' integrated journey.

We have three Growth Avenues that add value

by creating an integrated ecosystem

Diagnostic	Novos Elos	Health Platform
Medicine	Build relevant	Become the biggest
Grow while	performance	in engaged users
maintaining quality	in the value chain

Financial highlights

R$ 4.8 billion	R$ 1.2 billion
Gross Revenue (+15.1%)	recurring EBITDA (+9,1%)
R$ 4.5 billion	R$ 307.9 million
in net revenue (+15.2%)	Net Income (-12.0%)

Material facts

Inauguration of the	Business combination with
new headquarters in São Paulo (SP)	Hermes Pardini Institute
housing the New Operational Technical
Center (NTO)	•	30 brands
	•	487 service units
• Capacity of 500,000 tests per day	•	24 technical areas
• Social and environmental attributes	•	over 20,000 employees
such as energy efficiency, effluent	• 4,300 medical service providers
treatment and waste reduction	•	245 million tests a year

Click hereto learn more.

2

Business Units Highlights

Diagnostic	Reference hospitals/	Health	Novos Elos	Other fronts
Medicine	laboratories (LARE)	Platform		of action
• 10 more service units	•	21 hospitals	•	33.1% growth	• 8 more new units opened	•	SOMMOS DNA
•	Campana brand	•	774 customers		of Mobile Service	• Acquisition of Saha	•	Genesis
	expansion (6 new units in			•	84.4% growth	Hospital and Retina Clinic	•	Fertility
	the access segment)				in Digital Channels		•	Oncology
• Growth of operations in			•	120,000 services		•	Kortex Ventures
	the Northeast region				through Saúde iD
• 500 new products and
	methodology changes
•	Acquisition of Marcelo
	Magalhães Laborathory
	(PE) and Méthodos (MG)

452.4 thousand	over 110 million	76.76%
medical consultations performed	tests performed	Group General NPS

3

Innovation Highlights

Digital transformation journey

R$ 22.7 million

invested in Research, Development and Innovation

Reduction of R$ 34 million in costs

603

implementations of new products, services and methodologies

84

publications of scientific articles

40% compared to 2021

Pillars of digital transformation at Fleury Group:

CLOUD	CUSTOMER	AGILE
FIRST	EXPERIENCE	ENTERPRISE

StartupsArtificial intelligence

•	32 startups delivering	•	24,000 CT scans
	innovations for the		supported by
	Group		algorithms
•	"Impacta" Program,	•	812 impacted lives
	acceleration of
	ESG startups,
	in partnership
	with Quintessa -
	Aceleradora de
	Impacto

Personalized	Data Science and
medicine and	bioinformatics
genomics
•	35 new germline	• 20 new projects in
	genetic panels		Health Data Science
•	Reached 523 liquid	•	Big data partnership
	biopsy multigene		with the TrinetX
	panels		Platform
•	Unprecedented	•	over 50,000 hours
	techniques for		of development and
	the diagnosis		support of applications
	of autoimmune
	encephalitis

Highlights

15% self-service in the brands of the Group; with a+ SP expected to reach 30% by the end of 2023

Growth in mobile service supported by digital tools

Customer satisfaction above 82% in self-services

Automatic reading of exams with the image of the medical order

4

for the third year in the

ESG Performance

To learn more, access the full version of the Sustainability Report 2022.

Environmental

• 33.2% reduction in overall GHG emissions
• 28,168 tCO2 of GHG emissions avoided by energy efficiency projects
• 223,025.98 GJ of renewable energy
• Elaboration of 234 continuous improvement reports, focused on quality and environmental management
• 2 photovoltaic plants supplying 16% of the energy consumed by São Paulo units

Monitoring of targets

Indicator	Unit	Target	Result	Status
Non-
hazardous	Kg/exam	0.0130	0.0140	Unmet
waste
Biological	Kg/exam	0.0122	0.0099	Met
waste
Water	m3/exam	0.0027	0.0029	Unmet
Energy	Kwh/exam	0.8639	0.8847	Unmet
Paper	Pack/exam	0.00143	0.00139	Met
Total
Emissions	%	-10%	-33.20%	Surpassed
Reduction

Social

Communities

• 5,657 people directly benefited by private social investment actions
• 5,825 volunteers in social initiatives
• more than 63,000 beneficiaries assisted in classes C, D and E
• R$ 2.3 million invested in social responsibility projects
• Telemedicine booth in partnership with Instituto Gerando Falcões (85.9% resolvability)
• Target to reach 1.5 million patients from classes C, D and E by 2030

Employees

• 13,602* employees and 2,465 outsourced employees
• Average of 28 hours of training per employee
• More than 3,900 physicians
• Public commitments on diversity and inclusion
• Expansion of Affinity Groups

Suppliers

• 3,874 suppliers
• R$ 686 million spent with direct suppliers
• 45 companies engaged in the Supply Chain Relationship Excellence Program (PERC)

Corporate Governance

• 93.5% of adherence to the Code of Trust training (92% target achieved)
• Mandatory Risk Management training track for all employees
• Hiring consultancy to advance in Human Rigths risk management
• Melhores do ESG Award from Exame magazine
• Maintenance, since 2014, in the Corporate

Sustainability Index (ISE) and participation ICO2 index

(Carbon Efficient), both from B3

• Participation for the third consecutive time in the

Dow Jones Sustainability Index (DJSI) - Emerging Markets portfolio, as the only healthcare company in the Americas to be included in the index

• Commitment to the UN Global Compact since 2014
• Joining the Pact for the Promotion of Racial Equity and integration into the Bloomberg Gender-

Equality Index 2023, and inclusion in the TEVA

Women in Leadership Index

*The data disclosed does not include the acquired brands (Pretti, Bioclínico, Methodos and Marcelo Magalhães), Novos Elos (Saha, CIP, Moacir Cunha, Vita, Retina Clinic and Saúde ID) and Grupo Hermes Pardini.

5